Working with the University of Kentucky Markey Cancer Center, Lee Anne Pope is launching “Set Your Screen,” a new public ...

Carson, a Super Bowl champion and longtime advocate for men's health and prostate cancer awareness is in Buffalo at Roswell Park Comprehensive Cancer Center for an appearance with Thurman Thomas for ...

A new study revealed molecular features linked to more aggressive prostate cancer in a subset of patients who had been ...

Prostate cancer is the most commonly diagnosed cancer in American men — and the second leading cause of cancer-related deaths. One in eight men will be diagnosed in their lifetime. And Black men are ...

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine ...

Astellas Announced Presentation of 21 Abstracts at ESMO 2026 Including Prostate, Urothelial, GEJ, Lung and Pancreatic cancers ...

CHAPS, the leading prostate screening charity, is holding a unique workshop aiming to tackle the conflicting messages men are ...

Radiation therapy (RT) and radical prostatectomy (RP) have distinct morbidity profiles that support individualized treatment ...

Researchers at Fred Hutch Cancer Center have identified a previously overlooked molecular regulator that helps determine ...

A single tRNA can influence whether prostate cancer cells mutate and become difficult to treat with standard therapies.

Telix, an Australian-based biotechnology company with U.S. headquarters in Fishers, received FDA approval for the drug in September.

The questions relate to diagnosis and treatment options, but also to sexuality, continence, relationships and the possibility ...